CVRx, Inc. (CVRX) Key Metrics

NASDAQ: CVRXValuation, returns, debt and efficiency ratios over 7 years.

CVRX valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$34.6M
Enterprise value
$67.3M
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
0.6
10-yr median 16.6
Price / book
3.6
10-yr median 4.0
EV / EBITDA
—
Dividend yield
—
Beta
0.77

CVRX key metrics, 2019–2025

Fiscal year ended December 31, 2025 · U.S. dollars

CVRX valuation Price multiples at each fiscal year-end price.

Price / sales−41.4%
3.3
2025 · hover or tap a bar for each year
2021: 19.42022: 16.8 (−13.7%)2023: 16.6 (−1.0%)2024: 5.6 (−66.4%)2025: 3.3 (−41.4%)
20192025
Price / book+16.9%
4.7
2025 · hover or tap a bar for each year
2021: 1.72022: 3.5 (+98.8%)2023: 8.6 (+149.0%)2024: 4.0 (−53.1%)2025: 4.7 (+16.9%)
20192025
Free cash flow yield−7.9 pts
−22.0%
2025 · hover or tap a bar for each year
2021: −11.4%2022: −11.5% (−0.1 pts)2023: −6.1% (+5.4 pts)2024: −14.1% (−8.1 pts)2025: −22.0% (−7.9 pts)
20192025

CVRX valuation history

Fiscal year-endToday7-year median

CVRX returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

CVRX debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

CVRX cash returned to shareholders

DividendsBuybacksFree cash flow

CVRX price vs earnings per share

Share price at year-endEPS (right axis)

CVRX key metrics

2019–2025
CVRx, Inc. key metrics by fiscal year
2025202420232022202120202019
Valuation
Market capitalization$185.2M$286.3M$652.5M$376.8M$253.4M——
Enterprise value$160.3M$230.8M$592.6M$277.7M$111.3M——
Price / sales3.35.616.616.819.4——
Price / book4.74.08.63.51.7——
EV / sales2.84.515.112.48.5——
Earnings yield−28.8%−20.9%−6.3%−11.0%−17.0%——
Free cash flow yield−22.0%−14.1%−6.1%−11.5%−11.4%——
Shareholder yield (dividends + buybacks)———0.0%0.0%——
Share price at fiscal year-end$7.10$12.67$31.44$18.35$12.23——
Per share
Revenue per share$2.17$2.27$1.89$1.09$0.63——
Earnings per share−$2.04−$2.65−$1.99−$2.02−$2.08——
Operating cash flow per share−$1.54−$1.73−$1.88−$2.08−$1.34——
Free cash flow per share−$1.56−$1.79−$1.91−$2.11−$1.40——
Cash per share$2.90$4.69$4.36$5.17$6.86——
Book value per share$1.51$3.14$3.66$5.32$7.04——
Tangible book value per share$1.51$3.14$3.66$5.32$7.04——
Capex per share$0.02$0.06$0.03$0.03$0.06——
Debt per share$1.95$2.23$1.48$0.35———
Shares outstanding26.1M22.6M20.8M20.5M20.7M——
Change in shares outstanding+15.4%+8.9%+1.1%−0.9%———
Returns & profitability
Return on equity (ROE)−96.6%−81.6%−44.5%−32.5%———
Return on invested capital (ROIC)−270.4%−298.0%−261.3%−481.4%———
Return on assets (ROA)−44.8%−48.2%−34.3%−29.9%−39.6%−30.1%−50.3%
Return on tangible assets−50.9%−44.9%−35.8%−33.2%−28.2%−21.8%−50.3%
Free cash flow margin−71.9%−79.0%−100.8%−193.0%−221.8%−271.1%−206.0%
Financial health
Total debt$50.8M$50.4M$30.6M$7.1M—$19.3M$19.0M
Cash & short-term investments$75.7M$105.9M$90.6M$106.2M$142.1M$59.1M$25.7M
Net debt−$24.9M−$55.5M−$60.0M−$99.1M−$142.1M−$39.8M−$6.7M
Debt / equity1.290.710.400.06———
Debt / assets0.480.380.270.06—0.300.65
Current ratio7.6312.0614.2515.1925.578.073.36
Quick ratio6.7210.9412.8614.3324.927.653.12
Interest coverage-8.8-13.5-24.0-257.7-11.7-4.7-5.9
Working capital$88.3M$119.1M$104.2M$114.8M$145.2M$56.4M$20.3M
Invested capital$14.4M$15.6M$16.0M$10.1M$3.9M−$333.1M−$285.8M
Tangible asset value$39.3M$71.1M$75.9M$109.2M$146.0M−$293.2M−$279.0M
Net current asset value$36.2M$67.5M$72.8M$107.1M$144.5M−$293.7M−$279.2M
Graham net-net per share$0.93$2.50$3.01$4.77$6.73——
Capital allocation
Share buybacks (net)———$0$1,000$0—
Capex / revenue1.0%2.7%1.5%3.0%9.1%5.1%1.7%
Capex / depreciation0.772.201.131.667.044.151.89
Stock-based compensation / revenue19.5%37.1%16.0%17.3%14.7%2.2%1.1%
R&D / revenue19.7%21.7%29.6%44.3%57.5%105.9%138.4%
SG&A / revenue156.2%178.0%156.8%222.7%213.7%160.5%97.6%
Efficiency
Days sales outstanding64.259.860.665.553.860.341.9
Days of inventory on hand533.9505.6523.3395.6362.1686.3449.4
Days payables outstanding140.997.8105.181.449.8116.694.8
Cash conversion cycle (days)457.2467.7478.9379.8366.1630.0396.5
Receivables turnover5.686.106.025.576.796.058.70
Payables turnover2.593.733.474.497.333.133.85
Inventory turnover0.680.720.700.921.010.530.81
Asset turnover0.480.410.330.160.120.130.21
Average receivables$10.0M$8.4M$6.5M$4.0M$1.9M$1.0M$719,000
Average payables$3.2M$2.2M$1.8M$1.1M$496,500$460,000$437,000
Average inventory$12.2M$11.5M$9.0M$5.4M$3.6M$2.7M$2.1M
Intangibles / total assets0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Computed from CVRX's annual financial statements (latest annual report filed February 13, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

CVRX valuation and financial ratios

CVRx earned a return on equity of −96.6% and a return on invested capital of −270.4% in fiscal 2025. It ended the year with $50.8 million of debt and $75.7 million in cash and short-term investments, a net cash position of $24.9 million.

See the CVRX income statement, the CVRX chart for price history, or the CVRX stock overview for the latest quote and news.

CVRX key metrics FAQ

What is CVRx's return on equity?

CVRx's return on equity (ROE) was −96.6% in fiscal 2025: net income of -$53.3 million on average shareholders' equity of $55.2 million.

What is CVRx's ROIC?

CVRx's return on invested capital was −270.4% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does CVRx have?

CVRx had total debt of $50.8 million at the end of fiscal 2025, a debt-to-equity ratio of 1.29 and more cash than debt.

What is CVRx's free cash flow yield?

CVRx generated -$40.8 million of free cash flow in fiscal 2025, a free cash flow yield of −22.0% on its market value at year-end ($185.2 million).

What is CVRx's current ratio?

CVRx's current ratio was 7.63 at the end of fiscal 2025: current assets were 7.63 times current liabilities.

Medical Devices key metrics